Showing results (291-300 of 1,019) with videos related to

Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|June 27, 2019
Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in SpainMax Schlueter, Elaine Finn, Silvia Díaz, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 27, 2019
Abatacept: from a budget impact model to cost-effectiveness analysis - data from RCT and real lifeMaurizio Benucci, Arianna Damiani, Mariangela Manfredi, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 18, 2022
Sensor-Based Technology: Bringing Value to People with Diabetes and the Healthcare System in an Evolving WorldJudith L Glennie, Lori Berard, Fleur Levrat-Guillen
Clinicoeconomics and Outcomes Research : CEOR|March 25, 2022
Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health SystemAntoni Torres, Alex Soriano, Simone Rivolo, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 17, 2018
Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illnessJason Shafrin, Katalin Bognar, Katie Everson, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 25, 2018
A cost-benefit analysis of smoking cessation prescription coverage from a US payer perspectiveChristine L Baker, Yao Ding, Cheryl P Ferrufino, et al.
Clinicoeconomics and Outcomes Research : CEOR|August 25, 2016
Characterizing individual painDETECT symptoms by average pain severityAlesia Sadosky, Vijaya Koduru, E Jay Bienen, et al.
Clinicoeconomics and Outcomes Research : CEOR|May 30, 2017
Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximabTyler Knight, T Christopher Bond, Breanna Popelar, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 28, 2017
Economic and organizational sustainability of a negative-pressure portable device for the prevention of surgical-site complicationsEmanuela Foglia, Lucrezia Ferrario, Elisabetta Garagiola, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 8, 2016
A systematic review of observational studies evaluating costs of adverse drug reactionsFrancisco Batel Marques, Ana Penedones, Diogo Mendes, et al.
Pageof 102